三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301206 三元生物

已收盘 06-01 15:00:00

{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":25.55,"timestamp":1780297380000,"preClose":24.93,"halted":0,"volume":1117150,"delay":0,"changeRate":0.0249,"floatShares":130000000,"shares":202000000,"eps":0.4577,"marketStatus":"已收盘","change":0.62,"latestTime":"06-01 15:00:00","open":24.84,"high":25.62,"low":24.84,"amount":28319600,"amplitude":0.0313,"askPrice":25.55,"askSize":7,"bidPrice":25.52,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.4577,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780363800000},"marketStatusCode":5,"adr":0,"adjPreClose":24.93,"symbolType":"stock","openAndCloseTimeList":[[1780277400000,1780284600000],[1780290000000,1780297200000]],"highLimit":27.42,"lowLimit":22.44,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"isCdr":false,"pbRate":1.18,"roa":"--","peRate":55.822591,"roe":"0.61%","epsLYR":0.46,"committee":-0.394834,"marketValue":5169000000,"turnoverRate":0.0086,"status":0,"floatMarketCap":3329000000},"requestUrl":"/m/hq/s/301206","defaultTab":"news","newsList":[{"id":"2638555589","title":"三元生物(301206.SZ)拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2638555589","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638555589?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:09","pubTimestamp":1779718169,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三元生物(301206.SZ)披露2026年限制性股票激励计划(草案)，拟向激励对象授予的限制性股票数量为232.57万股，约占激励计划草案公告时公司股本总额的1.15%。本次授予为一次性授予，无预留权益。拟授予的激励对象共计76人，授予价格为13.42元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637387393","title":"三元生物（301206）披露2025年年度股东会决议公告，5月21日股价下跌2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637387393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637387393?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:36","pubTimestamp":1779359779,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，三元生物报收于25.94元，较前一交易日下跌2.52%，最新总市值为52.48亿元。该股当日开盘26.62元，最高26.91元，最低25.9元，成交额达3550.63万元，换手率为1.03%。近日，山东三元生物科技股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月20日召开2025年年度股东会，会议由董事会召集，董事长聂在建主持，采用现场与网络投票相结合方式召开。出席会议股东共75人，代表有表决权股份总数的48.3227%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635221419","title":"恒瑞医药与BMS刷新合作纪录；默沙东与多家药企签署协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2635221419","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635221419?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:02","pubTimestamp":1778630577,"startTime":"0","endTime":"0","summary":"政策动向国家药监局局长黄果会见新加坡卫生科学局局长蔡瑞文双方就创新医疗器械等议题深入交换意见国家药监局局长黄果5月11日在京会见了来访的新加坡卫生科学局局长蔡瑞文一行，并签署《中华人民共和国国家药品监督管理局与新加坡共和国卫生科学局监管合作谅解备忘录》。双方就细胞和基因治疗、创新医疗器械及人工智能产品监管等议题深入交换意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605133735150673.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d8fdac8d3d9097cb034fb43ab6bd5883","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605133735150673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","LU0211331839.USD","LU2491050154.USD","LU1064131003.USD","LU0234572021.USD","LU1781817850.SGD","LU0098860793.USD","BK4550","LU1934455194.USD","LU2543165471.USD","LU1064130708.USD","LU0122379950.USD","LU0320765489.SGD","IE00B1BXHZ80.USD","IE0009355771.USD","LU2097828714.EUR","LU1093756168.USD","LU1066051498.USD","BK4007","LU2106854487.HKD","LU0868494708.USD","LU2097828631.EUR","LU1655091616.SGD","BK4588","600276","LU0359202008.SGD","LU0208291251.USD","LU0648001328.SGD","LU0965509010.AUD","LU1934455277.USD","LU0130102774.USD","LU0265550359.USD","LU1023059063.AUD","LU2023250504.SGD","BK4559","LU0868494617.USD","LU0058720904.USD","LU2491050071.SGD","002022","BK0188","LU1023057109.AUD","SG9999014542.SGD","BK0012","IE00BJT1NW94.SGD","LU2491049909.HKD","LU2324357040.USD","LU1941712264.USD","LU1917777945.USD","LU1430594728.SGD","LU2361044865.SGD","LU0942090050.USD","IE00BFTCPJ56.SGD","LU2125154778.USD","LU2361044949.HKD","LU0359201612.USD","LU1035773651.USD","LU1989771016.USD","LU0859254822.USD","LU1580142542.USD","LU2357627491.SGD","LU2023250843.SGD","LU1116320737.USD","BK1191","LU2580892862.HKD","SG9999002232.USD","LU2125154935.USD","BK0196","IE00BSNM7G36.USD","LU2495084118.USD","LU0432979614.USD","LU1037948897.HKD","BK4516","LU1934455863.HKD","LU1328615791.USD","IE00BN8TJ469.HKD","LU1162221912.USD","LU1941712348.USD","LU2328871848.SGD","LU2488822045.USD","BK4585","LU1997245094.SGD","LU0965509283.SGD","SG9999015341.SGD","LU0289739699.SGD","LU1069347547.HKD","LU2097828557.USD","SG9999001176.SGD","301206","LU0266013472.USD","IE00B2B36J28.USD","LU2097828805.USD","LU1997244956.HKD","LU2112291526.USD","SG9999001176.USD","LU0320765646.SGD","SG9999001440.SGD","SG9999013999.USD","LU1571399168.USD","SG9999014559.SGD","IE00B4R5TH58.HKD","LU1066053197.SGD","IE0002141913.USD","LU0359201885.HKD","LU1061106388.HKD","LU1820825898.SGD","SGXZ57979304.SGD","LU1201861249.SGD","LU1066051811.HKD","IE00BBT3K403.USD","688506","LU1255011170.USD","01276","LU0070302665.USD","LU1989772840.SGD","IE000M9KFDE8.USD","SG9999014567.USD","LU0238689110.USD","LU2089984988.USD","BK0239","LU2289578879.USD","LU2361045086.USD","SG9999015358.SGD","LU1969619763.USD","LU1093756325.SGD","LU0405327494.USD","LU0965508806.USD","LU1291159041.SGD","LU0265550946.USD","BK0183","SG9999002224.SGD","LU0861579265.USD","BK4534","LU1974910355.USD","LU0965509101.SGD","LU1146622755.USD","LU2468319806.SGD","LU1997245177.USD","SG9999014575.USD","LU2461242641.AUD","LU0203347892.USD","BK0060","IE00BLSP4452.SGD","LU1989772923.USD","LU1699723380.USD","LU1116320901.HKD","LU1057294990.SGD","LU0106261372.USD","LU1037948541.HKD","LU1983299246.USD","LU0980610538.SGD","LU0006306889.USD","LU1585245621.USD","LU2148510915.USD","LU0130517989.USD","LU2097828474.EUR","LU1929549753.HKD","IE00BJJMRZ35.SGD","LU0477156953.USD","LU2580892789.USD","LU0203345920.USD","LU0405327148.USD","LU0985320562.USD","LU1066051225.USD","IE00BLSP4239.USD","LU2360032135.SGD","MRK","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634216715","title":"5月12日三元生物发布公告，股东减持100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634216715","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634216715?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:01","pubTimestamp":1778587300,"startTime":"0","endTime":"0","summary":"证券之星消息，5月12日三元生物发布公告《三元生物:关于持股5%以上股东权益变动触及1%整数倍暨减持计划实施完成的公告》，其股东吕熙安于2026年5月6日至2026年5月11日间合计减持100.0万股，占公司目前总股本的0.4943%，变动期间该股股价上涨0.81%，截止5月11日收盘报27.45元。股东增减持详情见下表：根据三元生物2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200036501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634090244","title":"三元生物：截至5月8日公司在册股东共15862户","url":"https://stock-news.laohu8.com/highlight/detail?id=2634090244","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634090244?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:48","pubTimestamp":1778489296,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)05月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问5月8日的股东人数是多少？三元生物回复：投资者您好，截至5月8日公司在册股东共15862户，谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633387114","title":"三元生物(301206)4月30日股东户数1.56万户，较上期增加1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633387114","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633387114?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:38","pubTimestamp":1778146739,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三元生物披露，截至2026年4月30日公司股东户数为1.56万户，较4月10日增加185.0户，增幅为1.2%。在化学制品行业个股中，三元生物股东户数低于行业平均水平，截至4月30日，化学制品行业平均股东户数为2.78万户。从股价来看，2026年4月10日至2026年4月30日，三元生物区间涨幅为2.56%，在此期间股东户数增加185.0户，增幅为1.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633153436","title":"股市必读：三元生物（301206）5月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633153436","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633153436?lang=zh_cn&edition=full","pubTime":"2026-05-07 02:02","pubTimestamp":1778090543,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，三元生物报收于27.12元，下跌0.4%，换手率1.23%，成交量1.61万手，成交额4380.59万元。随着2026年一季度营业收入实现同比49.65%的增长，前期储备存货正有序消化，不存在滞销情形。审计机构已出具报告，认定公司于2025年12月31日按照《企业内部控制基本规范》和相关规定，在所有重大方面保持了有效的财务报告内部控制。当日关注点来自交易信息汇总：5月6日主力资金净流出717.87万元，散户资金净流入856.47万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700001375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633790275","title":"三元生物：2025年末存货增长主要系公司基于市场预判进行的战略性备货","url":"https://stock-news.laohu8.com/highlight/detail?id=2633790275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633790275?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:00","pubTimestamp":1778054431,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物05月06日在投资者关系平台上答复投资者关心的问题。投资者提问：年报显示2025年存货余额增至1.75亿元，营收却下滑8.89%，存货跌价准备仅27万元。2025年末存货增长主要系公司基于市场预判进行的战略性备货。随着2026年一季度营业收入实现同比49.65%的增长，前期储备存货正有序消化，不存在滞销情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600021987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631071515","title":"三元生物（301206）披露2026年一季度报告，4月29日股价上涨3.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631071515","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631071515?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:53","pubTimestamp":1777463585,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，三元生物报收于27.01元，较前一交易日上涨3.49%，最新总市值为54.65亿元。该股当日开盘26.33元，最高27.11元，最低26.24元，成交额达6223.33万元，换手率为1.78%。公司于2026年4月29日披露《2026年一季度报告》。报告显示，2026年第一季度营业收入为224,781,048.39元，较上年同期增长49.65%；归属于上市公司股东的净利润为26,091,444.30元，同比增长4.73%；归属于上市公司股东的扣除非经常性损益的净利润为22,862,806.87元，同比增长9.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631258277","title":"图解三元生物年报：第四季度单季净利润同比增长0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631258277","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631258277?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:39","pubTimestamp":1777397988,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物2025年年报显示，当年度公司主营收入6.5亿元，同比下降8.89%；归母净利润9141.06万元，同比下降12.9%；扣非净利润7593.59万元，同比下降25.9%；其中2025年第四季度，公司单季度主营收入1.73亿元，同比下降12.4%；单季度归母净利润2401.19万元，同比上升0.28%；单季度扣非净利润1880.16万元，同比下降18.28%；负债率4.07%，投资收益6951.18万元，财务费用-507.28万元，毛利率16.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900004576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629070078","title":"股市必读：三元生物（301206）4月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2629070078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629070078?lang=zh_cn&edition=full","pubTime":"2026-04-23 04:39","pubTimestamp":1776890343,"startTime":"0","endTime":"0","summary":"截至2026年4月22日收盘，三元生物报收于26.15元，下跌0.42%，换手率0.6%，成交量7829.0手，成交额2045.69万元。董秘最新回复投资者： 董秘你好，有客户成批量购买贵公司的甜菊糖苷Rm了吗？公司莱鲍迪苷M目前处于市场拓展与导入阶段，已获得部分下游客户的积极反馈，市场推广工作有序开展。出于商业秘密保护要求，具体业务合作细节不便对外披露。交易信息汇总资金流向4月22日主力资金净流出192.95万元；游资资金净流入68.23万元；散户资金净流入124.72万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300010837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629558095","title":"三元生物：公司与国内外多家主流食品饮料企业均有深度合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2629558095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629558095?lang=zh_cn&edition=full","pubTime":"2026-04-22 11:30","pubTimestamp":1776828641,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)04月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，可口可乐在山姆新推出植物甜可乐，添加有高倍甜味剂甜菊糖苷，可口可乐为贵公司客户，甜菊糖苷是不是贵公司提供？三元生物回复：投资者您好！公司与国内外多家主流食品饮料企业均有深度合作。出于商业秘密保护要求，具体业务合作细节不便对外披露。公司将持续致力于为客户提供优质的健康甜味解决方案，感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200025507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206","000807.SH","159843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629095652","title":"三元生物：莱鲍迪苷M目前处于市场拓展与导入阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2629095652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629095652?lang=zh_cn&edition=full","pubTime":"2026-04-22 11:30","pubTimestamp":1776828641,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)04月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，有客户成批量购买贵公司的甜菊糖苷Rm了吗？三元生物回复：投资者您好！公司莱鲍迪苷M目前处于市场拓展与导入阶段，已获得部分下游客户的积极反馈，市场推广工作有序开展。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200025506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627425866","title":"股市必读：三元生物(301206)股东户数1.54万户，较上期减少0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627425866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627425866?lang=zh_cn&edition=full","pubTime":"2026-04-15 01:12","pubTimestamp":1776186731,"startTime":"0","endTime":"0","summary":"截至2026年4月14日收盘，三元生物报收于26.61元，上涨0.11%，换手率0.45%，成交量5838.0手，成交额1553.1万元。来自股本股东变化：截至4月10日股东户数环比下降0.89%，筹码集中度有所提升。股本股东变化股东户数变动近日三元生物披露，截至2026年4月10日公司股东户数为1.54万户，较3月31日减少139.0户，减幅为0.89%。户均持股数量由上期的1.3万股增加至1.31万股，户均持股市值为34.87万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500002838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624574974","title":"三元生物：截至3月31日公司在册股东共15546户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624574974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624574974?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:54","pubTimestamp":1775120075,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年3月31日公司股东人数是多少？谢谢！三元生物回复：投资者您好，截至3月31日公司在册股东共15546户，谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200027796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621081946","title":"股市必读：三元生物（301206）3月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2621081946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621081946?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:53","pubTimestamp":1774295588,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，三元生物报收于24.69元，下跌4.86%，换手率1.6%，成交量2.09万手，成交额5224.9万元。董秘： 投资者您好，截至3月20日公司在册股东共15634户，谢谢关注。当日关注点来自交易信息汇总：3月23日主力资金净流出344.26万元，显示主力短期减持动向。来自交易信息汇总：散户资金净流入302.26万元，反映散户投资者参与度上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621738137","title":"三元生物：截至3月20日公司在册股东共15634户","url":"https://stock-news.laohu8.com/highlight/detail?id=2621738137","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621738137?lang=zh_cn&edition=full","pubTime":"2026-03-23 15:48","pubTimestamp":1774252090,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问3月20日公司股东人数是多少？谢谢！三元生物回复：投资者您好，截至3月20日公司在册股东共15634户，谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300020253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620573412","title":"三元生物（301206）披露持股5%以上股东减持股份预披露公告，3月18日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620573412","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620573412?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:46","pubTimestamp":1773845173,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，三元生物报收于27.23元，较前一交易日上涨0.55%，最新总市值为55.09亿元。该股当日开盘27.07元，最高27.24元，最低26.85元，成交额达3306.11万元，换手率为0.94%。公司于近日披露《关于持股5%以上股东减持股份的预披露公告》。公告显示，持有山东三元生物科技股份有限公司6.4260%股份的股东吕熙安，计划自2026年4月10日至2026年7月9日，通过集中竞价方式减持不超过1,000,000股，占公司总股本的0.5%。减持价格将根据市场价格确定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620230818","title":"三元生物最新公告：股东吕熙安拟减持不超0.5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620230818","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620230818?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:11","pubTimestamp":1773832272,"startTime":"0","endTime":"0","summary":"三元生物公告称，持股5%以上股东吕熙安因个人资金需求，计划在未来3个月内（2026年4月10日至7月9日）以集中竞价方式减持公司股份不超过100万股，占公司总股本的0.5%。减持价格将根据市场价格确定。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800034296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619488679","title":"股市必读：三元生物(301206)股东户数1.6万户，较上期减少4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619488679","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619488679?lang=zh_cn&edition=full","pubTime":"2026-03-16 03:07","pubTimestamp":1773601631,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，三元生物报收于27.47元，下跌0.4%，换手率1.48%，成交量1.93万手，成交额5328.83万元。交易信息汇总资金流向3月13日主力资金净流出230.42万元；游资资金净流入398.66万元；散户资金净流出168.24万元。股本股东变化股东户数变动近日三元生物披露，截至2026年3月10日公司股东户数为1.6万户，较2月27日减少764.0户，减幅为4.55%。户均持股数量由上期的1.2万股增加至1.26万股，户均持股市值为34.62万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780315657358,"stockEarnings":[{"period":"1week","weight":-0.0467},{"period":"1month","weight":-0.077},{"period":"3month","weight":-0.1268},{"period":"6month","weight":-0.0811},{"period":"1year","weight":-0.1122},{"period":"ytd","weight":-0.0517}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0227},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.2096},{"period":"ytd","weight":0.0251}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"15862人(较上一季度增加1.73%)","perCapita":"8213股","listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","registeredCapital":"20232万元","survey":"　　山东三元生物科技股份有限公司的主营业务是糖醇类、功能糖类及糖苷类健康甜味配料的研发、生产与销售。公司的主要产品是赤藓糖醇、阿洛酮糖、塔格糖、甜菊糖。公司品牌先后荣获“山东知名品牌”及“山东优质品牌”称号。","listedPrice":109.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}